How were (CASC)'s earnings last quarter?

(CASC) (NASDAQ:CASC) posted its quarterly earnings results on Wednesday, November, 8th. The biopharmaceutical company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.01. During the same quarter in the prior year, the company earned ($0.09) earnings per share.

What other stocks do shareholders of (CASC) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CASC) investors own include Xtrackers California Municipal Bond ETF (CA) , Endologix (ELGX) , BlackRock (BLK) , Athabasca Oil (ATH) , Chipotle Mexican Grill (CMG) , Aegean Marine Petroleum Network (ANW) , NIC (EGOV) , ALJ Regional (ALJJ) , Gran Tierra Energy (GTE) and Transocean (RIG) .

NASDAQ:CASC

(CASC) (CASC) Stock Price, News & Analysis

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)

Free CASC Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $10.02
▼
$10.02
50-Day Range: N/A
52-Week Range: $3.18
▼
$10.21

Volume: N/A
Average Volume: 1.09 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (CASC) alerts:

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About (CASC) Stock (NASDAQ:CASC)

Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutic products for the treatment of cancer. The Company's clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule human epidermal growth factor receptor (HER) 2 inhibitor. The Company's ONT-10 is a therapeutic vaccine targeting the Mucin 1 peptide antigen (MUC1). The Company is engaged in developing preclinical product candidates in oncology using its Checkpoint kinase 1 (Chk1) kinase inhibitor and protocell technology. The Company completed the evaluation of approximately two dosing cohorts in its Phase Ib trial of ONT-10 in combination with the anti-CD27 T-cell agonist antibody varlilumab in collaboration with other company. The Company has completed Phase I trial of ONT-380, with both dose-escalation and expansion components. The Company has initiated Phase Ib trials of ONT-380.

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

CASC Stock News Headlines

April 15, 2024 | msn.com

China’s 130-ton reusable rocket engine breaks records during tests

April 12, 2024 | finance.yahoo.com

Global Wooden Satellite Market Size is Expected to Hold a Significant Share By 2033 | CAGR Of 7.3%

April 19, 2024 | Behind the Markets (Ad)

Forget NVIDIA, buy this $2 AI stock now…

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

April 12, 2024 | msn.com

Aberdeen establishment handed new "requires improvement" food hygiene rating

April 11, 2024 | msn.com

Northern Ireland Maritime and Offshore Network (NIMO) aims to propel NI’s rich maritime excellence

April 4, 2024 | msn.com

Catching reusable space rockets with tight-wire net, China’s new plan

April 3, 2024 | msn.com

China plans to catch its reusable rockets with constricting wires (video)

April 2, 2024 | morningstar.com

Cascade Copper Corp CASC

April 19, 2024 | Behind the Markets (Ad)

Forget NVIDIA, buy this $2 AI stock now…

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

April 1, 2024 | msn.com

Why China Might Beat the U.S. Back to the Moon

March 15, 2024 | msn.com

SpaceX CEO Elon Musk Warns Space Rivals To Up Their Game Or End Up 'In the Noise': 'There Isn't Enough To Do Just Launching Satellites'

March 8, 2024 | msn.com

Does China need a space data bureau to support its ever-growing satellite networks?

March 7, 2024 | msn.com

Artistic swimmers want more members to dive in

March 6, 2024 | msn.com

China’s space agency could own reusable rockets before NASA

February 28, 2024 | msn.com

China Wants to Rival NASA With 100 Space Launches in One Year

February 27, 2024 | msn.com

China plans 100 launches into space

February 26, 2024 | msn.com

China’s Space Ambitions Grow With Big Leap in Rocket Launches

February 26, 2024 | msn.com

China’s Communication Satellite No. 11 Launched Successfully: New Heights in Space Exploration

February 21, 2024 | finance.yahoo.com

Setting South Carolina Students Up for Success: Virtual Schools Open for Enrollment

February 15, 2024 | juniorminingnetwork.com

Cascade Copper Highlights 2023 Exploration Results and 2024 Programs

February 9, 2024 | news.yahoo.com

Stitt wants EOSC and CASC to be more 'aggressive' in talks of partnership

February 8, 2024 | news.yahoo.com

EOSC Board of Regents pass MOU to share resources with CASC

February 8, 2024 | msn.com

China is embarking on a science and exploration program of staggering scale

February 7, 2024 | msn.com

China's deep-space ambition

February 6, 2024 | msn.com

China's New Hyperloop Train Just Hit a Record 387 MPH During Testing

February 4, 2024 | msn.com

Explore the unforgettable scotch whisky trail in Scotland

February 2, 2024 | msn.com

Chinese company's reusable rocket prototype aces launch-and-landing test (photos)

See More Headlines

Receive CASC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CASC) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/08/2017
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Biotechnology
Current Symbol: NASDAQ:CASC
CUSIP: 68232410
CIK: 1412067
Web: www.cascadianrx.com
Phone: +1-206-8012100
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Christopher S. Henney Ph.D. (Age 76)
Chairman of the Board
Scott D. Myers (Age 51)
President, Chief Executive Officer, Director
Julia Marie Eastland (Age 51)
Chief Financial Officer, Vice President - Corporate Development, Secretary
Gary W. Christianson (Age 61)
Chief Operating Officer
Scott Peterson Ph.D. (Age 54)
Chief Scientific Officer
Robert W. Azelby (Age 49)
Director
Gwendolyn A. Fyfe M.D. (Age 65)
Independent Director
Steven P. James (Age 58)
Independent Director
Ted W. Love M.D. (Age 58)
Independent Director
Daniel Keith Spiegelman (Age 58)
Independent Director

CASC Stock Analysis - Frequently Asked Questions

How were (CASC)'s earnings last quarter?: (CASC) (NASDAQ:CASC) posted its quarterly earnings results on Wednesday, November, 8th. The biopharmaceutical company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.01. During the same quarter in the prior year, the company earned ($0.09) earnings per share.
What other stocks do shareholders of (CASC) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (CASC) investors own include Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), NIC (EGOV), ALJ Regional (ALJJ), Gran Tierra Energy (GTE) and Transocean (RIG).

This page (NASDAQ:CASC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(CASC) (CASC) Stock Price, News & Analysis

About (CASC) Stock (NASDAQ:CASC)

CASC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

CASC Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info